On Feb. 16, I will be participating in a panel on the possible direction the new administration's policies may take toward the biotechnology and pharmaceutical industries as part of the Council for Entrepreneurial Development's 18th annual biotech conference. I will be joined by Robert Ingram, Dennis Gillings, Victor Dzau and Maureen Kelley O'Connor, some of the great minds in health care and health policy in our state. I look forward to being a part of this discussion and hope you will join us. Read more about the panel here.
How do you think the new administration's policies will affect the biotechnology and pharmaceutical industries?